Table 1 Study participants and institutions.
Institution (Consortium) | Participants | Participated in: | |||
|---|---|---|---|---|---|
| Â | Â | Exp. 1 (fixed activated blood) | Exp. 2 (shipped whole blood) | Exp. 3 (cryo-preserved PBMC) | Exp. 4 (cryo-preserved PBMC with lyoplates) |
University of Montreal (CANVAC) | Rafick Sekaly, Eva Roig, Claire Landry | x | Â | x | x |
Chelsea and Westminster Hospital (IAVI) | Jill Gilmour, Peter Hayes | x | Â | x | x |
Uganda Virus Research Institute (IAVI) | Josephine Birungi, Omu Anzala | Â | Â | Â | x |
Centre Hospitalier Universitaire Vaudois (EUROVAC) | Giuseppe Pantaleo, Alexandre Harari, Miguel Garcia | x | Â | x | x |
Fred Hutchison Cancer Research Center (HVTN) | Helen Horton ,Ruth Baydo, Ian Frank | x | x | x | x |
Duke University (HVTN) | Kent Weinhold, Janet Ottinger, Megan Baker, Jennifer Holbrook | x | x | Â | x |
Vaccine Research Center, NIH | Mario Roederer, Richard Koup, Laurie Lamoreaux | x | x | x | x |
Merck and Co. | Timothy Tobery, Lynda Tussey, Kara Punt | x | x | x | x |
University of California, San Francisco | Barry Bredt, Elizabeth Sinclair, Lorrie Epling | x | x | Â | x |
BD Biosciences | Vernon Maino, Holden Maecker, Maria Suni | x | x | x | x |
Sanofi Pasteur | Nolwenn Nougarede, Sophia El-Bahi | Â | Â | Â | x |
National Inst. Communicable Diseases, South Africa | Clive Gray, Hazel Maila | Â | Â | Â | x |
Massachusetts General Hospital | Marcus Altfeld, Gailet Alter | Â | Â | Â | x |
University of Pennsylvania | Jean Boyer, Sandra Calarota | Â | Â | Â | x |
Henry Jackson Foundation | Josephine Cox, Ellen Kuta | Â | Â | Â | x |